Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group

NCT03967834 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT03967834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03967834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group
Lead sponsor
Institut Claudius Regaud
Phase
Not applicable
Overall status
Recruiting
Start date
April 26, 2021
Completion date
April 30, 2031
Enrollment
400 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

alveolar soft part sarcoma, clear cell sarcoma, desmoplastic small round cell tumor, epithelioid hemangioendothelioma, epithelioid sarcoma, low grade fibromyxoid sarcoma, malignant solitary fibrous tumors, perivascular epithelioid cell neoplasms, sclerosing epithelioid fibrosarcoma, soft tissue sarcoma